Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06300242 · ClinicalTrials.gov registry record · NA
Incentives for Influenza Vaccination
A NA study of Influenza Vaccination, sponsored by University of Southern California.
- Completed
- Registry status
- NA
- Development phase
- 69,972
- Enrollment target
- 1
- Study location
NCT06300242: Completed NA study of Influenza Vaccination, sponsored by University of Southern California.
NCT06300242 is a NA study of Influenza Vaccination that has completed, run by University of Southern California. The registered enrollment target is 69,972 participants, above the 14,550-participant average among 3 other Influenza Vaccination trials with a reported enrollment target (381% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06300242, a NA study of Influenza Vaccination, has completed, sponsored by University of Southern California.
- COMPLETED
- Registry status
- NA
- Development phase
- 69,972 participants
- Enrollment target
- 1
- Study location
Study Summary
In this work, we are assessing the impact of messaging with or without a $50 financial incentive on influenza vaccination rates in a county health system. Our main hypothesis is that a message with a $50 financial incentive will increase vaccination rates relative to a control/"treatment as usual" group. We further hypothesize that the financial incentive will increase vaccination rates relative to the message only arm.
Primary Outcome
influenza vaccination status as documented in the EMR and from the California Immunization Registry (CAIRS)
Conditions Studied
Interventions
- OTHER Placebo
- BEHAVIORAL Reminders
- BEHAVIORAL Financial Incentive
Study Locations (1)
California
- Contra Costa Health Services - Martinez
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 69,972 participants |
| Start Date | 2024-01-17 |
| Est. Completion | 2024-02-29 |
| Phase | NA |
What the finished NCT06300242 record still lists
NCT06300242 is an interventional study that assigns participants to a tested intervention. Its 69,972 participants enrollment target places it among the larger protocols in the corpus, above the 14,550-participant average among 3 other Influenza Vaccination trials with a reported enrollment target (381% higher).
The record links to 1 condition, with Influenza Vaccination appearing as the primary indexed condition, and to 3 interventions - of which Placebo is the first listed.
NCT06300242 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT06300242 about?
NCT06300242 is a clinical study titled "Incentives for Influenza Vaccination". In this work, we are assessing the impact of messaging with or without a $50 financial incentive on influenza vaccination rates in a county health system. Our main hypothesis is that a message with a $50 financial incentive will increase vaccination rates relative to a control/"treatment as usual" g...
What is the current status of trial NCT06300242?
This trial is currently completed. It is a NA study. The enrollment target is 69,972 participants. The study started on 2024-01-17. Estimated completion is 2024-02-29.
What conditions does trial NCT06300242 study?
This clinical trial studies the following conditions: Influenza Vaccination.
What interventions are being tested in trial NCT06300242?
The interventions under investigation include: Placebo (OTHER), Reminders (BEHAVIORAL), Financial Incentive (BEHAVIORAL).
Who is sponsoring clinical trial NCT06300242?
This trial is sponsored by University of Southern California, which has 617 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06300242 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Influenza Vaccination
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00009633 · 68,000 participants
Follow-up Visit of High Risk Infants
- NCT06903897 · 68,000 participants · NA
Social Needs Screening and Chronic Diseases Study (WE CARE)
- NCT04473833 · 65,000 participants · NA
Transvaginal Ultrasonography as a Screening Method for Ovarian Cancer
- NCT02402244 · 75,000 participants
Project: Every Child for Younger Patients With Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI